Search & Analyze

Procter & Gamble Health Ltd.

5,697.00+186.40 (+3.38%)

BSE · 30 Oct, 4:01 PM

: ₹9,435.75 Cr
: 26.44
: 365
: ₹5,713.10 - ₹5,452.45
: ₹6,955.00 - ₹4,699.70

Procter & Gamble Health Ltd. (PGHL) share price closed at ₹5,697.00 on the BSE on Friday, October 30, 2026, up by 3.38% from its of ₹5,510.60. In that session PGHL reached a of 5,713.10 and of 5,452.45. The for the session was 5,597.26. The stands at 5,468.26 and is at 5,578.11. Looking at , the stock ended the session in Uptrend.

Stock Overview

₹5,466.20

₹5,510.60

₹5,597.26

₹5,468.26

Price 4.18% above

₹5,578.11

Price 2.13% above

Key Fundamentals

: 9,435.75 Cr₹9.44 Thousand Crore
: 215.00
: 26.44
: 15.33
: 370.86
: 483.11 Cr₹483.11 Crore
: 3.61 %
Sector
Industry: Pharmaceuticals & Drugs
: 62.18
: 0.00

Industry Comparison

Ratio	Company	Sector
	26.44	44.48
	0.00	0.10
	15.33	4.89
	2.18	1.97
	3.61 %	0.13 %
Operating Margin	28.90 %	20.36 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	129.27	4,26,661.74	0.90	871.29	54.42%	6,141.92	35.04%	13.27
DIVI'S LAB. DIVISLAB	9,715.00	87.69	2,57,902.73	0.31	891.00	59.96%	2,974.00	26.18%	21.89
TORRENT PHAR TORNTPHARM	4,635.15	86.68	1,76,306.21	0.82	498.00	-16.58%	4,145.00	50.07%	19.77
LAURUSLABS LAURUSLABS	2,392.00	123.68	1,29,242.68	0.08	388.13	79.96%	2,014.11	28.57%	16.08
ZYDUSLIFE ZYDUSLIFE	1,244.00	35.31	1,24,089.48	0.08	339.60	-11.72%	2,872.20	10.97%	16.05
DR.REDDY'S DRREDDY	1,350.20	115.98	1,12,698.53	0.59	695.80	79.65%	5,572.60	20.66%	12.67
CIPLA LTD. CIPLA	1,380.00	42.06	1,11,488.55	0.94	787.03	-34.98%	5,067.42	-3.03%	14.04
Procter & Gamble Health Ltd. PGHL	5,697.00	26.44	9,435.75	3.61	96.15	45.29%	363.71	7.37%	84.86

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	252.48	283.88	313.41	309.77	310.99	338.74	324.92	373.86	370.45	363.71
Expenses	185.04	235.63	199.37	186.34	230.07	248.40	204.65	263.40	234.86	264.11
	67.44	48.25	114.04	123.43	80.92	90.34	120.27	110.46	135.59	99.60
	26.71%	17.00%	36.39%	39.85%	26.02%	26.67%	37.02%	29.55%	36.60%	27.38%
	2.27	-18.06	3.28	3.96	3.11	4.03	4.95	4.36	4.00	35.68
Interest	0.15	0.20	0.15	0.15	0.13	0.12	0.12	0.10	0.21	0.14
	6.84	7.16	5.77	5.55	5.37	5.44	6.08	5.90	6.17	6.02
	62.72	22.83	111.40	121.69	78.53	88.81	119.02	108.82	133.21	129.12
	25.77%	26.50%	26.10%	25.30%	22.09%	25.48%	25.61%	28.70%	28.98%	25.53%
	46.56	16.78	82.33	90.90	61.18	66.18	88.54	77.59	94.60	96.15
	28.05	10.11	49.60	54.76	36.86	39.87	53.34	46.74	56.99	57.92

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Jun)	FY 2022-23 (Jun)	FY 2023-24 (Jun)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	9.00	12.00
INCOME :
	1,177.84	1,328.24	1,259.24	1,029.07	1,567.29
	1,114.41	1,229.62	1,151.26	934.17	1,407.97
EXPENDITURE :
Increase/Decrease in Stock	-4.75	2.85	0.87	14.75	-12.83
Raw Material Consumed	344.55	358.99	329.69	247.75	377.91
Power & Fuel Cost	14.70	12.88	8.50	5.82	7.33
Employee Cost	167.56	206.17	215.16	142.06	222.56
Other Manufacturing Expenses	132.01	126.07	113.33	81.00	143.14
General and Administration Expenses	60.88	87.16	99.67	68.56	102.57
Selling and Distribution Expenses	109.45	74.49	52.65	42.33	88.90
Miscellaneous Expenses	22.33	36.33	25.39	13.51	25.41
	846.73	904.94	845.26	615.78	954.99
Operating Profit (Excl OI)	267.68	324.68	306.00	318.39	452.98
	13.19	18.39	15.63	10.35	21.02
	280.87	343.07	321.63	328.74	474.00
Interest	0.42	0.77	0.72	0.43	0.55
PBDT	280.45	342.30	320.91	328.31	473.45
	27.08	28.10	27.40	16.69	23.59
Profit Before Taxation & Exceptional Items	253.37	314.20	293.51	311.62	449.86
Exceptional Income / Expenses			-20.19
	253.37	314.20	273.32	311.62	449.86
Provision for Tax	60.85	84.73	72.34	77.21	122.95
	192.52	229.47	200.98	234.41	326.91
Extra items	0.00	0.00		0.00	0.00
Consolidated Net Profit	192.52	229.47	200.98	234.41	326.91
Profit Balance B/F	327.70	237.07	370.91	157.57	159.93
Appropriations	520.22	466.54	571.89	391.98	486.84
Equity Dividend %	525.00%	950.00%	2,600.00%	1,250.00%	2,050.00%
	115.98	138.23	121.07	141.21	196.93
Adjusted EPS	115.98	138.23	121.07	141.21	196.93

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Jun)	FY 2022-23 (Jun)	FY 2023-24 (Jun)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	16.60	16.60	16.60	16.60	16.60
Share Warrants & Outstandings	7.28	7.84	8.53	4.89	5.10
Total Reserves	592.61	726.45	513.11	515.47	502.85
Reserve excluding Revaluation Reserve	592.61	726.45	513.11	515.47	502.85
	616.49	750.89	538.24	536.96	524.55
Deferred Tax Assets / Liabilities	-19.65	-25.32	-33.69	-35.06	-30.70
Other Long Term Liabilities	0.60	9.53	7.57	5.81	7.17
Long Term Provisions	732.68	818.79	29.64	36.12	54.70
Total Non-Current Liabilities	713.63	803.00	3.52	6.87	31.17
Trade Payables	172.08	237.04	167.00	171.60	192.17
Other Current Liabilities	42.32	42.49	38.22	33.29	39.98
Short Term Provisions	393.33	399.55	13.69	10.42	22.78
Total Current Liabilities	607.73	679.08	218.91	215.31	254.93
Total Liabilities	1,937.85	2,232.97	760.67	759.14	810.65
Gross Block	241.11	263.07	223.32	222.08	231.21
Less: Accumulated Depreciation	131.32	121.35	96.72	110.34	131.50
Less: Impairment of Assets	0.73
	109.06	141.72	126.60	111.74	99.71
	40.60	32.49	5.89	10.96	13.59
Long Term Loans & Advances	801.72	885.23	102.06	105.68	138.58
Total Non-Current Assets	953.98	1,061.69	236.45	232.75	254.39
Inventories	115.21	134.94	109.11	109.37	136.65
Sundry Debtors	83.44	115.71	85.33	145.40	164.26
Cash and Bank	324.53	440.22	244.36	188.55	185.29
Other Current Assets	7.95	13.73	24.17	23.12	20.15
Short Term Loans and Advances	452.74	466.68	61.25	59.95	49.91
Total Current Assets	983.87	1,171.28	524.22	526.39	556.26
Net Current Assets (Including Current Investments)	376.14	492.20	305.31	311.08	301.33
Total Assets	1,937.85	2,232.97	760.67	759.14	810.65
	181.19	156.51	162.50	182.29	174.73
Total Debt	0.00	0.00	0.00	0.00	0.00
	366.99	447.62	319.10	320.52	312.92
Adjusted Book Value	366.99	447.62	319.10	320.52	312.92

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Jun)	FY 2022-23 (Jun)	FY 2023-24 (Jun)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	9.00	12.00
	253.37	314.20	273.32	311.62	449.86
Adjustment	27.31	41.49	52.27	12.20	15.18
Changes In working Capital	-47.30	-30.02	-12.12	-73.81	-23.40
Cash Flow after changes in Working Capital	233.38	325.67	313.47	250.01	441.64
Cash Flow from Operating Activities	169.52	236.01	228.29	168.69	337.79
Cash Flow from Investing Activities	-25.54	-21.50	-6.87	9.59	1.26
Cash Flow from Financing Activitie	-288.63	-98.47	-418.11	-234.74	-343.92
Net Cash Inflow / Outflow	-144.65	116.04	-196.69	-56.46	-4.87
Opening Cash & Cash Equivalents	464.05	319.40	435.42	238.73	182.27
Closing Cash & Cash Equivalent	319.40	435.44	238.73	182.27	177.40

Ratios

Valuation

26.44

15.33

19.15

6.58

215.00

370.86

Profitability

62.18

84.86

41.65

28.90

20.86

Leverage & Liquidity

0.00

2.18

818.93

Returns

3.61

2.00

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82	51.82
	20.94	21.45	21.73	21.08	21.15	21.15	20.81	19.87	18.77	19.05
	27.23	26.74	26.46	27.11	27.03	27.04	27.37	28.31	29.42	29.13
	48.18	48.18	48.18	48.18	48.18	48.18	48.18	48.18	48.18	48.18
No. of Shareholders	55,923	54,792	53,736	53,993	52,478	50,006	49,302	50,883	49,056	50,426

Mutual Funds Invested(29)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 20 active funds hold 8.77% in Procter & Gamble Health Ltd., contributing to ₹810 Cr of holdings

Fund				As of
NI Nippon India Small Cap Fund - Growth - Direct PlanSmall cap Fund	386.44	0.48	6,94,659	Sep '26
UT UTI MNC Fund - Growth - Direct PlanMNC	105.63	4.03	1,89,876	Sep '26
DS DSP Healthcare Fund - Growth - Direct PlanPharma & Health Care	88.61	2.36	1,59,288	Sep '26
AB Aditya Birla Sun Life MNC Fund - Growth - Direct PlanMNC	52.69	1.74	94,716	Sep '26
TA Tata India Pharma & Healthcare Fund - Growth - Direct PlanPharma & Health Care	41.50	2.75	74,596	Sep '26
UT UTI Healthcare Fund - Growth - Direct PlanPharma & Health Care	27.82	1.95	50,000	Sep '26
AB Aditya Birla Sun Life Consumption Fund - Growth - Direct PlanConsumption	24.76	0.43	44,504	Sep '26
BF Bajaj Finserv Small Cap Fund - Growth - Direct PlanSmall cap Fund	20.09	0.73	36,120	Sep '26
AB Aditya Birla Sun Life Pharma & Healthcare Fund - Growth - Direct PlanPharma & Health Care	19.58	1.82	35,195	Sep '26
AB Aditya Birla Sun Life Business Cycle Fund - Growth - Direct PlanEquity - Thematic Fund - Other	15.79	0.92	28,381	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-09-30	Board Meeting	Quarterly Results
2026-08-12	AGM
2026-06-29	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Procter & Gamble Health Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Zeal Rupani

Company Secretary & Compliance Officer

—

S Madhavan

Chairman

₹22.50 L

Mar '26

Aalok Agrawal

Non Executive Director

—

Seema Sambasivan

Non Executive Director

—

Krishna Sarma

Non Executive Independent Director

₹21.25 L

Mar '26

Sharad Tyagi

Non Executive Independent Director

₹21.75 L

Mar '26

Shashank Srowthy

Executive Director & Chief Financial Officer

₹64.74 L

Mar '26

Milind Thatte

Managing Director

₹3.18 Cr

Mar '26

PGHL Latest News

News

3 of 3 articles

EQUITY18 Jun 2026 · 11:23

Procter & Gamble Health submits presentation

EQUITY4 Jun 2026 · 15:59

Procter & Gamble Health informs about analyst meet

EQUITY26 May 2026 · 17:03

Procter&Gamble Healt reports Profit after tax of Rs 946.00 Mln, in the March 2026 quarter

Procter & Gamble Health Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(29)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

PGHL Latest News

News